Cargando…

Antagonistic TNF Receptor One-Specific Antibody (ATROSAB): Receptor Binding and In Vitro Bioactivity

BACKGROUND: Selective inhibition of TNFR1 signaling holds the potential to greatly reduce the pro-inflammatory activity of TNF, while leaving TNFR2 untouched, thus allowing for cell survival and tissue homeostasis. ATROSAB is a humanized antagonistic anti-TNFR1 antibody developed for the treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richter, Fabian, Liebig, Timo, Guenzi, Eric, Herrmann, Andreas, Scheurich, Peter, Pfizenmaier, Klaus, Kontermann, Roland E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747052/ https://www.ncbi.nlm.nih.gov/pubmed/23977237 http://dx.doi.org/10.1371/journal.pone.0072156

Ejemplares similares

Selective Targeting of TNF Receptors as a Novel Therapeutic Approach
por: Fischer, Roman, et al.
Publicado: (2020)

Process development of ATROSAB, an anti TNFR1 Monoclonal Antibody: in three steps from research to GMP
por: Landauer, Karlheinz, et al.
Publicado: (2011)

TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice
por: Wandrer, Franziska, et al.
Publicado: (2020)

A TNF Receptor 2 Selective Agonist Rescues Human Neurons from Oxidative Stress-Induced Cell Death
por: Fischer, Roman, et al.
Publicado: (2011)

Selective Blocking of TNF Receptor 1 Attenuates Peritoneal Dialysis Fluid Induced Inflammation of the Peritoneum in Mice
por: Kälble, Florian, et al.
Publicado: (2016)

Antitumor Activity of a Mesenchymal Stem Cell Line Stably Secreting a Tumor-Targeted TNF-Related Apoptosis-Inducing Ligand Fusion Protein
por: Marini, Irene, et al.
Publicado: (2017)

The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation
por: Richter, Fabian, et al.
Publicado: (2021)

Membrane Tumor Necrosis Factor (TNF) Induced Cooperative Signaling of TNFR60 and TNFR80 Favors Induction of Cell Death Rather Than Virus Production in HIV-infected T Cells
por: Lazdins, Janis K., et al.
Publicado: (1997)

Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2
por: Fischer, Roman, et al.
Publicado: (2017)

Co-modulation of TNFR1 and TNFR2 in an animal model of multiple sclerosis
por: Fiedler, Timon, et al.
Publicado: (2023)

Duokines: a novel class of dual-acting co-stimulatory molecules acting in cis or trans
por: Fellermeier-Kopf, Sina, et al.
Publicado: (2018)

Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells
por: Hutt, Meike, et al.
Publicado: (2018)

Continuous infusion of an agonist of the tumor necrosis factor receptor 2 in the spinal cord improves recovery after traumatic contusive injury
por: Gerald, Marcus J., et al.
Publicado: (2019)

The TNFR1 antagonist Atrosimab reduces neuronal loss, glial activation and memory deficits in an acute mouse model of neurodegeneration
por: Ortí-Casañ, Natalia, et al.
Publicado: (2023)

Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MS
por: Pegoretti, Valentina, et al.
Publicado: (2023)

Trivalent soluble TNF Receptor, a potent TNF-α antagonist for the treatment collagen-induced arthritis
por: Cui, Xiaofang, et al.
Publicado: (2018)

The Transmembrane Domains of TNF-Related Apoptosis-Inducing Ligand (TRAIL) Receptors 1 and 2 Co-Regulate Apoptotic Signaling Capacity
por: Neumann, Simon, et al.
Publicado: (2012)

IgG-single-chain TRAIL fusion proteins for tumour therapy
por: Siegemund, Martin, et al.
Publicado: (2018)

A Novel Anti-Kv10.1 Nanobody Fused to Single-Chain TRAIL Enhances Apoptosis Induction in Cancer Cells
por: Hartung, Franziska, et al.
Publicado: (2020)

Superior Treg-Expanding Properties of a Novel Dual-Acting Cytokine Fusion Protein
por: Padutsch, Tanja, et al.
Publicado: (2019)

Cortistatin binds to TNF-α receptors and protects against osteoarthritis
por: Zhao, Yunpeng, et al.
Publicado: (2019)

Modulation of Glutamate Transport and Receptor Binding by Glutamate Receptor Antagonists in EAE Rat Brain
por: Sulkowski, Grzegorz, et al.
Publicado: (2014)

The Pharmacokinetics of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone
por: Heinig, Roland, et al.
Publicado: (2023)

A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity
Publicado: (1991)

EGFR-Targeted TRAIL and a Smac Mimetic Synergize to Overcome Apoptosis Resistance in KRAS Mutant Colorectal Cancer Cells
por: Möller, Yvonne, et al.
Publicado: (2014)

Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody
Publicado: (1991)

Effective use of TNF antagonists
por: Yocum, David
Publicado: (2004)

In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii
por: Ricci, Susanna, et al.
Publicado: (2003)

Fluorescent CXCR4 chemokine receptor antagonists: metal activated binding
por: Khan, Abid, et al.
Publicado: (2007)

Heterogeneity reduces sensitivity of cell death for TNF-Stimuli
por: Schliemann, Monica, et al.
Publicado: (2011)

Endothelin Receptors and Their Antagonists()()
por: Maguire, Janet J., et al.
Publicado: (2015)

Antagonistic control of tumor necrosis factor receptors by protein kinases A and C. Enhancement of TNF receptor synthesis by protein kinase A and transmodulation of receptors by protein kinase C
Publicado: (1989)

Comparative effectiveness of treatment with the first TNF antagonist in monotherapy, the first TNF antagonist plus one conventional synthetic disease-modifying antirheumatic drug, and the first TNF antagonist plus two or more conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
por: Hernández-Cruz, Blanca, et al.
Publicado: (2016)

Interaction between Antagonist of Cannabinoid Receptor and Antagonist of Adrenergic Receptor on Anxiety in Male Rat
por: Komaki, Alireza, et al.
Publicado: (2014)

Low-Level Endothelial TRAIL-Receptor Expression Obstructs the CNS-Delivery of Angiopep-2 Functionalised TRAIL-Receptor Agonists for the Treatment of Glioblastoma
por: Krishna Moorthy, Nivetha, et al.
Publicado: (2021)

Binding, Thermodynamics, and Selectivity of a Non-peptide Antagonist to the Melanocortin-4 Receptor
por: Saleh, Noureldin, et al.
Publicado: (2018)

Structural insights into the subtype-selective antagonist binding to the M2 muscarinic receptor
por: Suno, Ryoji, et al.
Publicado: (2018)

New Insights into the Stereochemical Requirements of the Bombesin BB1 Receptor Antagonists Binding
por: Rasaeifar, Bahareh, et al.
Publicado: (2020)

Computational studies of the binding modes of A(2A) adenosine receptor antagonists
por: Ye, Y., et al.
Publicado: (2007)

Effect of Dopamine D(2) Receptor Antagonists on [(18)F]-FEOBV Binding
por: Schildt, Anna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6c0cbjvi1kklkvlfqr3vlp80dj